97856 Implementation of DPYD and UGT1A1 pharmacogenetic testing to guide chemotherapy dosing
ABSTRACT IMPACT: The implementation of DPYD and UGT1A1 pharmacogenetic testing, a promising tool of precision medicine, translates evidence-based research into clinical oncology practice with personalized dosing to better predict interpatient variability in chemotherapy tolerability. OBJECTIVES/GOAL...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Cambridge University Press
2021-03-01
|
| Schriftenreihe: | Journal of Clinical and Translational Science |
| Online-Zugang: | https://www.cambridge.org/core/product/identifier/S205986612100666X/type/journal_article |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|